| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $0 | — |
| SG&A Expense | $129K | -89.4% |
| Operating Income | -$5.5M | -325.9% |
| Interest Expense | $100K | — |
| Pre-tax Income | -$6.2M | -402.0% |
| Net Income | -$6.2M | -556.9% |
| EPS (Basic) | -$0.32 | -540.0% |
| EPS (Diluted) | -$0.32 | -540.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $64K | -63.1% |
| Current Assets | $158K | -20.9% |
| Total Assets | $2.5M | -87.4% |
| Current Liabilities | $1.2M | -46.1% |
| Total Liabilities | $1.3M | -84.6% |
| Stockholders' Equity | $1.2M | +116.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.9M | -133.4% |
| Investing Cash Flow | -$123K | -100.1% |
| Financing Cash Flow | $3.1M | +103.1% |